Lyme disease

AB1_LYME

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 A69.2
  • Hospital discharge: ICD-10 A69.2
  • Hospital discharge: ICD-9 1048A
  • Cause of death: ICD-10 A69.2
  • Cause of death: ICD-9 1048A

3 out of 7 registries used, show all original rules.

10872

4. Check minimum number of events

None

10872

5. Include endpoints

None

10872

6. Filter based on genotype QC (FinnGen only)

10872

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF12

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 10872 6819 4053
Unadjusted period prevalence (%) 2.12 2.32 1.79
Median age at first event (years) 63.14 62.12 64.85

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2779
Matched controls
27787
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A69.2
ICD-10 Finland
Lyme disease
718.8
323.0
2573
478
TAB00
NOMESCO Finland
Lumbar puncture
9.7
193.2
418
499
G63.0*A69.2
ICD-10 Finland
Polyneuropathy (in) Lyme disease
1339.9
132.4
128
*
S12
ICPC
Insect bite/sting
4.6
112.9
435
1081
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
+∞
96.4
92
*
J01CA04
ATC
amoxicillin; systemic
2.9
96.2
2391
18928
M01.2*A69.2
ICD-10 Finland
Arthritis in Lyme disease
+∞
95.3
91
*
1048A
ICD-9 Finland
Other spirochaetal infection, Other specified spirochaetal infections[MORBUS LYME]
+∞
78.5
75
*
G51.0
ICD-10 Finland
Bell palsy
7.2
73.5
187
277
J01AA02
ATC
doxycycline; systemic
2.3
68.8
2267
18291
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.1
51.1
314
1109
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
39.1
550
2983
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.2
39.0
425
2064
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
3.6
38.6
184
536
L548, A692
ICD-10 Finland
NA
+∞
38.6
37
*
M04AB01
ATC
probenecid; oral
34.1
36.3
47
14
M25.5
ICD-10 Finland
Pain in joint
1.8
36.1
821
5279
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
34.3
522
2905
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
29.3
1192
8904
N73
ICPC
Neurological infection other
66.7
28.9
33
5
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
28.7
201
764
H02AB06
ATC
prednisolone; systemic
1.6
28.3
1265
9636
R51.80
ICD-10 Finland
Headache
2.0
27.9
415
2273
R20.2
ICD-10 Finland
Paraesthesia of skin
2.6
27.9
221
906
H02AB07
ATC
prednisone; oral
1.9
26.2
411
2295
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.4
24.8
219
950
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
24.1
632
4152
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
23.4
280
1399
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
23.3
294
1505
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.2
23.1
247
1177
Z2221
NOMESCO Finland
Medical doctor
1.6
22.2
737
5136
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.9
22.0
92
241
N03AX16
ATC
pregabalin; oral
1.6
21.7
646
4376
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.2
21.6
227
1070
G63.0
ICD-10 Finland
Polyneuropathy in infectious and parasitic diseases classified elsewhere
115.9
21.6
23
*
M79.1
ICD-10 Finland
Myalgia
1.9
21.1
350
1984
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.3
20.8
206
944
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.3
20.5
191
849
W57
ICD-10 Finland
Bitten or stung by nonvenomous insect and other nonvenomous arthropods
3.7
20.1
88
241
M01AH05
ATC
etoricoxib; oral
1.4
19.4
1539
12845
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
19.3
275
1473
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
18.7
160
681
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
18.7
748
5416
M01AE02
ATC
naproxen; oral, rectal
1.4
17.9
1463
12191
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.3
17.4
88
272
S72
ICPC
Scabies/other acariasis
6.2
17.3
46
75
DFF00
NOMESCO Finland
Pure tone audiometry
1.9
17.1
244
1308
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
4.7
16.7
57
124
F02.89*A69.2
ICD-10 Finland
Dementia in Lyme disease
+∞
16.7
16
*
S29
ICPC
Skin symptom/complaint other
1.6
16.7
441
2875
M79.6
ICD-10 Finland
Pain in limb
1.4
16.4
892
6845
J05AB11
ATC
valaciclovir; oral
1.7
16.0
345
2117
AA1AD
NOMESCO Finland
CT of head and brain
1.5
15.9
598
4244
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.0
15.9
197
997
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
15.8
518
3559
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
5.2
15.4
47
91
R52.9
ICD-10 Finland
Pain, unspecified
1.9
15.2
232
1274
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.7
15.1
103
389
A02BC05
ATC
esomeprazole; systemic
1.4
15.0
1038
8299
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
14.9
553
3901
R42
ICD-10 Finland
Dizziness and giddiness
1.5
14.9
530
3708
S73
ICPC
Pediculosis/skin infestation other
9.2
14.7
30
33
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.2
14.4
74
233
H53.1
ICD-10 Finland
Subjective visual disturbances
2.1
14.2
168
838
R50.9
ICD-10 Finland
Fever, unspecified
1.7
14.1
341
2160
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.8
13.8
230
1301
A02BC02
ATC
pantoprazole; systemic
1.4
13.6
1647
14368
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
13.5
1006
8102
J01DB01
ATC
cefalexin; oral
1.4
13.5
2129
19399
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
13.5
401
2680
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.7
13.5
90
337
N02BE01
ATC
paracetamol; systemic, rectal
1.4
13.4
2257
20809
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.6
13.2
376
2486
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
13.1
861
6782
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
13.0
809
6304
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
9.4
12.9
26
28
R51
ICD-10 Finland
Headache
2.2
12.9
133
624
G44.2
ICD-10 Finland
Tension-type headache
1.6
12.8
324
2077
M01.2
ICD-10 Finland
Arthritis in Lyme disease
50.2
12.8
15
*
G01
ICD-10 Finland
Meningitis in bacterial diseases classified elsewhere
+∞
12.5
12
*
H48.1*A69.2
ICD-10 Finland
Retrobulbar neuritis in Lyme disease
+∞
12.5
12
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
12.5
523
3776
SPAT1152
SPAT
Removal of foreign body from under the skin
2.8
12.4
79
289
N06AX21
ATC
duloxetine; oral
1.7
12.1
255
1552
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.5
12.0
94
385
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
12.0
333
2189
R06AX27
ATC
desloratadine; oral
1.4
11.9
618
4651
Z01.2
ICD-10 Finland
Dental examination
1.3
11.7
989
8084
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
11.6
1133
9460
A98
ICPC
Health maint/preventive medicine
1.8
11.6
2628
25233
SPAT1249
SPAT
Treatment-related counselling outside office
0.7
11.6
652
8245
SPAT1262
SPAT
Handing over of treatment supplies
0.6
11.5
204
3198
WX002
NOMESCO Finland
Sedation and analgesia
1.5
11.5
479
3450
L82
ICD-10 Finland
Seborrhoeic keratosis
1.5
11.5
373
2541
V18
ICD-10 Finland
Pedal cyclist injured in noncollision transport accident
5.9
11.5
31
53
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.4
11.5
884
7115
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.2
11.4
115
533
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.2
11.3
112
518
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
11.0
591
4463
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.7
11.0
241
1485
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
10.9
549
4099
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.7
10.8
216
1297
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
4.2
10.7
39
93
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
10.7
279
1800
R53
ICD-10 Finland
Malaise and fatigue
1.5
10.7
462
3345
J01FA10
ATC
azithromycin; systemic
1.3
10.7
1426
12406
103
Kela drug reimbursment
Diabetes, insulin-treated
0.7
10.7
341
4743
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
10.6
425
3033
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.6
10.6
315
2101
N03AX12
ATC
gabapentin; oral
1.5
10.5
377
2627
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
10.5
888
7228
E0000UV
ATC
NA
1.3
10.5
923
7557
XQ800
NOMESCO Finland
Prick test
1.8
10.4
183
1057
X58
ICD-10 Finland
Exposure to other specified factors
1.6
10.3
312
2089
H53.2
ICD-10 Finland
Diplopia
2.5
10.3
79
321
S01GX01
ATC
cromoglicic acid; ophthalmic
1.4
10.0
451
3289
R4110
NOMESCO Finland
Physiotherapy
1.4
10.0
642
4993
D22
ICD-10 Finland
Melanocytic naevi
2.2
10.0
96
439
M03BX02
ATC
tizanidine; oral
1.3
10.0
1551
13714
D07AC01
ATC
betamethasone; topical
1.3
10.0
796
6411
P01BA02
ATC
hydroxychloroquine; oral
1.7
10.0
215
1321
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
0.7
9.8
383
5153
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
9.8
245
1568
A86
ICD-10 Finland
Unspecified viral encephalitis
6.5
9.7
24
37
XF640
NOMESCO Finland
NA
2.5
9.7
76
314
I50.0
ICD-10 Finland
Congestive heart failure
0.4
9.7
29
804
R06.0
ICD-10 Finland
Dyspnoea
1.4
9.7
573
4398
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.8
9.6
60
216
Z01.7
ICD-10 Finland
Laboratory examination
1.6
9.6
263
1722
R01AD08
ATC
fluticasone; nasal
1.4
9.6
669
5268
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
9.4
635
4973
M54.5
ICD-10 Finland
Low back pain
1.3
9.4
766
6177
CS494
NOMESCO Finland
Other visual field testing
2.6
9.3
67
264
G03.9
ICD-10 Finland
Meningitis, unspecified
10.7
9.3
17
16
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
9.2
193
1176
SPAT1324
SPAT
Screening procedure
0.6
9.2
178
2742
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.6
9.0
226
1446
XA800
NOMESCO Finland
Neuropsychological investigation
2.1
9.0
100
489
R52.2
ICD-10 Finland
Other chronic pain
2.2
8.9
86
395
J01MA02
ATC
ciprofloxacin; systemic
1.3
8.9
917
7633
M13.9
ICD-10 Finland
Arthritis, unspecified
1.7
8.9
173
1030
TNG10
NOMESCO Finland
Puncture of knee
3.5
8.8
39
112
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
8.8
273
1840
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
8.7
581
4537
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.7
8.7
284
3947
G35
ICD-10 Finland
Multiple sclerosis
3.1
8.7
45
146
R00.2
ICD-10 Finland
Palpitations
1.7
8.7
169
1006
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
3.0
8.7
48
163
D01AE16
ATC
amorolfine; topical
1.5
8.6
273
1847
R05
ICD-10 Finland
Cough
1.4
8.6
452
3390
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.6
8.5
224
1448
J37.0
ICD-10 Finland
Chronic laryngitis
2.3
8.5
75
331
NG2AA
NOMESCO Finland
Patella X-ray examination
2.4
8.5
69
293
R07.3
ICD-10 Finland
Other chest pain
1.6
8.5
216
1389
XF402
NOMESCO Finland
ECG with work load test
1.5
8.5
261
1758
I78.1
ICD-10 Finland
Naevus, non-neoplastic
2.4
8.4
66
275
C01CA24
ATC
epinephrine; parenteral
1.8
8.4
140
795
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
8.4
188
1168
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.6
8.4
221
1432
H22.0*A69.2
ICD-10 Finland
Iridocyclitis in Lyme disease
+∞
8.3
8
*
ZX120
NOMESCO Finland
Intravenous
1.6
8.3
220
1426
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.7
8.3
172
1047
J01MA12
ATC
levofloxacin; systemic
1.4
8.2
415
3089
N06AB10
ATC
escitalopram; oral
1.4
8.2
424
3169
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
3.1
8.2
43
141
205
Kela drug reimbursment
Chronic hypertension
0.7
8.2
381
5004
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
8.1
193
1219
M01AB05
ATC
diclofenac; systemic, rectal
1.3
8.1
1660
15011
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.5
8.0
262
1785
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.2
8.0
77
354
WX720
NOMESCO Finland
Own respiration
0.3
8.0
14
499
Z3226
NOMESCO Finland
Physiotherapist
1.4
7.9
434
3273
H93.1
ICD-10 Finland
Tinnitus
1.7
7.9
150
888
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.1
7.9
88
432
UKC02
NOMESCO Finland
Cystoscopy
1.4
7.9
347
2516
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
7.9
107
568
A02BC04
ATC
rabeprazole; oral
1.6
7.8
200
1287
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
7.8
201
1293
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.9
7.8
46
163
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
7.8
1098
9476
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
4.1
7.8
28
68
UJF32
NOMESCO Finland
Coloscopy
1.3
7.8
609
4863
T90
ICPC
Diabetes non-insulin dependent
0.7
7.8
305
4114
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.2
7.8
78
368
H02AB04
ATC
methylprednisolone; systemic
1.4
7.7
333
2408
A84.8
ICD-10 Finland
Other tick-borne viral encephalitis
45.1
7.7
9
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
7.7
913
7712
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.9
7.7
44
152
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.6
7.7
204
1324
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.7
7.6
333
4416
XG410
NOMESCO Finland
Flow-volume spirometry
2.0
7.6
97
505
109
Kela drug reimbursment
Multiple sclerosis
3.7
7.5
31
85
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
5.4
7.5
21
39
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
7.5
621
4996
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.4
7.5
62
267
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.9
7.5
110
603
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.4
7.4
58
240
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.2
7.4
72
332
D19
ICPC
Teeth/gum symptom/complaint
1.3
7.4
585
4675
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.7
7.4
147
886
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
3.9
7.3
28
72
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.7
7.3
155
949
A10BA02
ATC
metformin; oral
0.7
7.3
384
4959
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.3
7.2
561
4470
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
7.2
222
1496
J01MA01
ATC
ofloxacin; systemic
1.6
7.2
187
1206
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
7.2
400
3024
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
7.2
214
1431
XQ802
NOMESCO Finland
Epicutan test
2.0
7.2
91
471
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
1.9
7.1
93
489
R4120
NOMESCO Finland
Occupational therapy
1.7
7.1
146
889
J05AB01
ATC
aciclovir; systemic
1.3
7.1
476
3712
N32.0
ICD-10 Finland
Bladder-neck obstruction
4.0
7.1
26
65
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
2.6
7.0
49
193
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
7.0
936
8004
XQ855
NOMESCO Finland
Skin temperature measurement
5.2
6.9
20
39
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.0
6.9
81
408
J01FF01
ATC
clindamycin; systemic
1.3
6.9
624
5074
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
2.2
6.9
66
302
R60.0
ICD-10 Finland
Localized oedema
1.5
6.9
231
1587
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.5
6.9
49
196
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.8
943
8082
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
2.5
6.8
49
197
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.3
6.8
58
254
N02AX02
ATC
tramadol; systemic, rectal
1.2
6.8
984
8483
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.4
6.8
273
1946
C10AC01
ATC
colestyramine; oral
2.2
6.8
63
288
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
3.6
6.8
28
78
D01BA02
ATC
terbinafine; oral; topical
1.3
6.7
566
4558
M54
ICD-10 Finland
Dorsalgia
1.5
6.6
229
1582
A87.9
ICD-10 Finland
Viral meningitis, unspecified
4.2
6.6
23
55
K07.60
ICD-10 Finland
Snapping jaw
1.8
6.6
106
599
A10AE04
ATC
insulin glargine; parenteral
0.6
6.6
77
1334
H25.8
ICD-10 Finland
Other senile cataract
1.5
6.6
220
1511
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.6
6.6
177
1156
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.4
6.5
30
697
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
6.5
473
3728
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
6.5
373
2834
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
6.5
725
6052
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
6.5
957
8258
M79.7
ICD-10 Finland
Fibromyalgia
2.0
6.5
77
390
G01AA10
ATC
clindamycin; vaginal
1.4
6.4
317
2345
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.0
6.4
77
391
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
6.4
244
1721
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
6.4
357
2699
Z04
ICD-10 Finland
Examination and observation for other reasons
2.6
6.4
43
167
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
2.4
6.4
52
222
Z04.3
ICD-10 Finland
Examination and observation following other accident
2.3
6.4
56
250
G04CA01
ATC
alfuzosin; oral
1.5
6.4
228
1588
T78.4
ICD-10 Finland
Allergy, unspecified
1.8
6.4
99
555
D82
ICPC
Teeth/gum disease
1.3
6.3
763
6425
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
6.3
175
1152
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.4
6.3
25
617
WX408
NOMESCO Finland
General anesthesy, balanced
1.3
6.3
614
5036
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.9
6.3
90
490
H58.8*A69.2
ICD-10 Finland
Ophthalmopathy in Lyme disease
+∞
6.2
6
*
SPAT1255
SPAT
Intravenous administration of medicine
1.6
6.2
149
947
L90.4
ICD-10 Finland
Acrodermatitis chronica atrophicans
26.7
6.2
8
*
D07AD01
ATC
clobetasol; topical
1.4
6.2
336
2529
I50.1
ICD-10 Finland
Left ventricular failure
0.4
6.2
18
501
S06
ICPC
Rash localized
1.7
6.2
129
791
XF404
NOMESCO Finland
Ambulatory ECG
1.5
6.2
204
1399
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.5
6.2
225
1573
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
6.1
1298
11617
M02.8
ICD-10 Finland
Other reactive arthropathies
5.3
6.1
17
32
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.0
6.1
75
386
N02CC06
ATC
eletriptan; oral
2.0
6.1
70
350
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
6.1
377
2901
A10BB12
ATC
glimepiride; oral
0.5
6.1
47
916
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.4
6.1
235
1665
S18
ICPC
Laceration/cut
1.2
6.0
978
8508
Z00.0
ICD-10 Finland
General medical examination
1.3
6.0
392
3037

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
321
273
12.09
317.41
1.1
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
2951
5985
6.40
307.65
3.3
2.3
au/ml
37.3
23.5
5.54
259
298
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
2553
5516
5.74
307.65
1.7
1.2
au/ml
61.6
45.3
3.07
293
196
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
352
288
12.60
307.65
1.1
1.1
ng/l
1178.7
564.6
0.61
99
69
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
300
308
9.99
260.72
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
439
877
5.17
206.84
1.1
1.1
au/ml
32.3
3.6
—
14
5
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
2186
11575
2.11
189.99
4.7
4.6
%
32.9
32.5
0.69
1253
7916
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
188
175
10.91
174.85
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
376
765
5.06
173.27
1.1
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
615
2234
2.86
120.87
1.2
1.4
mg/l
578.8
535.4
1.12
594
2115
(3016018) Differential panel - Cerebral spinal fluid
357
929
3.94
120.03
1.3
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
534
1813
3.05
118.50
1.2
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
544
1954
2.88
109.00
1.2
1.3
mmol/l
3.5
3.8
6.69
502
1831
(3019225) pH of Specimen
1637
9385
1.88
107.16
3.6
4.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
142
177
8.12
105.96
1.1
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
95
78
12.28
95.80
1.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
4950
38783
1.51
91.22
2.2
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
281
8083
0.33
78.83
4.1
4.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
232
612
3.85
76.47
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
285
865
3.36
76.08
1.3
1.6
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
242
663
3.71
75.54
1.1
1.2
mg/l
55.4
39.3
2.85
231
548
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
9532
87747
1.70
69.86
12.0
13.4
ml/min/173m2
81.5
80.9
2.22
7797
72629
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
230
642
3.64
69.85
1.1
1.1
mg/l
340.8
254.6
4.69
219
555
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
234
695
3.42
64.65
1.2
1.4
mmol/l
1.9
2.1
3.41
212
653
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
343
8027
0.41
60.13
2.6
3.9
mmol/l
1.2
1.2
0.80
309
6995
(3029937) Albumin [Presence] in Urine by Test strip
1748
24888
0.65
58.78
3.8
4.2
estimate
0.0
0.0
2.99
402
8449
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2992
22640
1.44
58.37
2.2
2.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
169
450
3.80
55.04
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
497
9743
0.49
54.00
2.7
3.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
6550
57005
1.37
53.84
3.1
2.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
168
453
3.75
53.74
1.3
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
9071
83819
1.50
50.92
14.7
15.4
%
39.8
39.7
0.89
7062
59695
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
431
1985
2.22
50.63
1.3
1.5
e6/l
316.1
1461.2
2.14
325
1612
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2756
35235
0.71
50.55
3.4
3.9
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
429
1985
2.21
49.82
1.3
1.4
e6/l
33.1
32.5
0.02
315
1528
(3013707) Erythrocyte sedimentation rate by Westergren method
7738
69609
1.39
49.20
4.5
4.2
mm/h
10.7
12.4
24.10
7033
64514
(3041096) Erythrocytes [Presence] in Urine by Automated
1792
24590
0.68
48.17
2.7
3.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
164
469
3.54
48.11
1.1
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
76
117
6.53
47.06
1.2
1.4
%
78.5
50.7
4.70
43
48
(3000963) Hemoglobin [Mass/volume] in Blood
10624
102704
2.51
46.86
20.0
21.3
g/l
135.8
135.1
6.77
10443
101373
(3026361) Erythrocytes [#/volume] in Blood
10621
102681
2.49
46.50
19.9
21.2
e12/l
4.5
4.5
2.09
10229
99878
(3010813) Leukocytes [#/volume] in Blood
10622
102700
2.49
46.40
19.9
21.2
e9/l
6.4
6.7
33.91
10268
99868
(3024731) MCV [Entitic volume]
10620
102673
2.48
46.39
19.8
21.1
fl
91.2
91.1
2.13
10428
101339
(3035941) MCH [Entitic mass]
10619
102665
2.48
46.27
19.8
21.1
pg
30.4
30.3
4.39
10428
101330
(3007461) Platelets [#/volume] in Blood
10614
102619
2.45
45.83
19.9
21.2
e9/l
247.3
252.8
17.23
10290
100105
(3006462) Nitrate [Presence] in Urine
151
423
3.61
45.72
4.3
3.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
196
653
3.04
44.89
2.7
2.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1648
11608
1.49
44.88
5.3
6.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
3932
32246
1.34
44.24
6.3
6.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
4535
38218
1.32
41.38
2.1
2.0
pmol/l
101.0
96.6
6.30
2084
19644
(4211845)
153
463
3.34
41.16
4.2
3.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
5174
44592
1.31
39.35
6.2
6.0
%
55.8
57.1
12.73
4755
41615
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
10292
98818
1.78
39.33
11.0
10.7
u/l
25.7
26.1
1.68
9827
95391
(3047181) Lactate [Moles/volume] in Blood
71
2974
0.23
38.54
3.6
6.1
mmol/l
1.3
1.3
0.18
66
2623
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
271
1155
2.38
38.22
1.8
2.1
mg/l
22.7
25.1
0.28
58
315
(3033658) Prothrombin time (PT) actual/Normal
2986
23964
1.34
37.30
3.5
4.0
%
92.4
91.0
2.66
2907
23362
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
95
221
4.33
37.28
1.1
1.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
4945
42581
1.30
36.93
6.5
6.2
%
0.7
0.7
10.91
4524
39649
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
94
220
4.30
36.60
1.1
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
5075
43889
1.29
36.50
6.4
6.2
%
3.0
2.9
2.00
4658
40831
(3019069) Monocytes/100 leukocytes in Blood
5098
44129
1.29
36.34
6.7
6.5
%
8.7
8.6
0.72
4694
41263
(3002030) Lymphocytes/100 leukocytes in Blood
5205
45246
1.29
35.61
6.5
6.2
%
29.3
28.0
14.01
4741
42080
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
9753
92748
1.50
35.02
13.1
14.3
mg/l
22.0
23.3
3.44
7512
73565
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
51
71
7.21
34.68
1.1
1.3
%
7.3
26.4
1.71
21
19
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
91
217
4.22
34.60
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
92
224
4.13
34.04
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
2131
16471
1.37
33.48
1.3
1.3
iu/ml
36.8
34.7
0.14
585
5221
(40758558) Short blood count panel - Blood
2952
23963
1.32
33.27
7.3
7.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1737
13027
1.40
32.75
1.4
1.3
titre
468.4
534.6
0.82
342
2788
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
9114
85803
1.38
32.70
5.1
4.9
mu/l
1.9
2.1
1.34
8064
78749
(40761511) CBC panel - Blood by Automated count
10036
96211
1.56
32.63
11.6
13.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
2020
15562
1.37
32.25
1.3
1.3
u/ml
11.8
12.8
0.23
607
6029
(3008152) Bicarbonate [Moles/volume] in Arterial blood
295
5835
0.49
32.14
7.3
7.2
mmol/l
24.9
24.6
1.03
282
5434
(40768443) Skin Pathology biopsy report
689
4281
1.65
32.08
1.2
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
85
205
4.17
31.87
1.1
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
6081
54362
1.27
31.32
8.7
9.4
e9/l
3.7
4.1
21.28
5155
47437
(3001604) Monocytes [#/volume] in Blood
5322
46835
1.27
31.22
6.3
5.9
e9/l
0.6
0.6
19.75
4474
40340
(3013115) Eosinophils [#/volume] in Blood
5496
48561
1.27
31.14
6.4
6.2
e9/l
0.2
0.2
1.70
4698
42531
(3006315) Basophils [#/volume] in Blood
5334
47047
1.26
30.33
6.3
6.0
e9/l
0.0
0.0
0.06
4482
40529
(3014051) Protein [Presence] in Urine by Test strip
397
2145
1.88
30.06
2.3
2.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
5433
48118
1.26
29.44
6.2
6.0
e9/l
1.9
1.9
1.97
4626
42259
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
425
2368
1.83
29.19
1.2
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
58
111
5.25
28.80
1.1
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
2689
32488
0.77
28.50
2.4
2.9
—
—
—
0
0
(3010421) pH of Blood
73
2520
0.28
28.41
3.2
4.0
ph
7.4
7.4
0.74
56
2120
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2027
15893
1.34
28.39
2.7
2.8
e6/l
0.9
1.3
1.89
1097
9085
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
4875
42761
1.25
28.27
4.9
6.1
mmol/l
1.2
1.2
19.59
4253
38784
(3037467) Urinalysis macro (dipstick) panel - Urine
7006
64057
1.26
28.24
4.3
4.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
251
1180
2.15
28.09
1.4
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
340
6142
0.54
27.67
3.9
4.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1894
14765
1.34
27.47
3.3
3.0
ug/l
0.7
0.8
0.65
1278
9932
(3027315) Oxygen [Partial pressure] in Blood
56
2175
0.25
26.83
3.7
4.1
kpa
8.6
8.6
0.02
56
2137
(3044640) Blood type and Crossmatch panel - Blood
3509
29761
1.26
26.76
2.2
2.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
56
2158
0.26
26.48
3.7
4.1
kpa
5.0
5.0
0.10
56
2121
(3012501) Base excess in Blood by calculation
56
2156
0.26
26.44
3.7
4.1
mmol/l
1.9
2.5
1.95
45
1487
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1548
20015
0.74
26.34
1.5
1.7
pmol/l
28513850.4
33056594.3
0.12
1231
16596
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
56
113
4.98
26.21
1.1
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
9771
93731
1.42
25.75
5.1
5.0
mmol/l
2.8
2.8
9.51
8785
86363
(3017181) Myelocytes/100 leukocytes in Blood
519
8214
0.61
25.57
4.2
4.1
%
0.8
0.9
0.32
167
2342
(3025159) Blasts/100 leukocytes in Blood
451
7377
0.59
25.43
4.2
4.2
%
0.0
0.3
1.83
141
1840
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
9277
88285
1.35
25.37
4.1
4.0
mmol/l
1.2
1.3
20.42
8215
80760
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
9554
91378
1.38
24.94
4.7
4.4
mmol/l
1.5
1.5
24.28
8571
84202
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
9613
92038
1.38
24.90
4.5
4.5
mmol/l
4.8
4.7
12.54
8661
85281
(3013247) Albumin in CSF/Albumin in Serum or Plasma
64
153
4.20
24.36
1.0
1.1
mg/g
9.5
6.8
1.37
59
142
(3007164) IgA [Mass/volume] in Serum or Plasma
2221
17976
1.30
24.25
1.5
1.5
g/l
2.3
2.4
1.24
1134
10824
(3021440) Promyelocytes/100 leukocytes in Blood
496
7815
0.62
23.91
4.2
4.2
%
0.1
0.1
1.90
153
2176
(40767503) Oxygen content in Capillary blood by calculation
57
2046
0.27
23.84
2.1
2.5
%
16.1
16.2
0.08
35
1061
(3002179) Metamyelocytes/100 leukocytes in Blood
471
7492
0.61
23.63
4.0
4.0
%
0.8
0.6
0.39
121
1707
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
9444
90307
1.35
23.46
4.7
4.6
mmol/l
5.8
5.9
34.83
8353
82502
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
125
468
2.69
23.30
1.4
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
65
164
3.98
23.04
1.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1642
20665
0.76
22.61
4.2
4.6
—
—
—
0
0
(3013512) EKG study
3192
27226
1.24
22.14
4.0
3.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
6664
61342
1.22
21.83
4.3
4.5
e6/l
2491.6
1529.8
0.24
25
801
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
420
2543
1.68
21.59
1.4
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
134
541
2.50
21.46
1.1
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
9928
95915
1.40
21.23
14.5
16.5
mmol/l
3.9
4.0
7.54
9605
93507
(3020564) Creatinine [Moles/volume] in Serum or Plasma
10161
98586
1.47
21.15
14.9
16.7
umol/l
74.2
76.1
15.68
10155
98555
(3019550) Sodium [Moles/volume] in Serum or Plasma
9904
95655
1.40
21.11
14.3
16.4
mmol/l
139.9
139.7
12.86
9616
93419
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1829
14683
1.30
20.87
2.8
2.9
e6/l
2.2
2.7
1.48
907
7922
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
6634
61199
1.22
20.59
3.1
3.1
u/l
43.4
48.5
4.90
6055
56948
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
407
2496
1.66
19.93
1.3
1.3
u/ml
3.3
6.6
2.35
49
409
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
7722
72430
1.23
19.88
7.6
7.7
u/l
74.9
78.3
12.50
7135
68333
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
346
2034
1.72
19.86
1.2
1.3
u/ml
1.2
5.3
1.99
21
147
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
546
3599
1.54
19.75
3.1
3.9
mmol/l
24.9
24.9
0.26
509
3321
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
414
2558
1.64
19.69
1.4
1.4
iu/ml
20.1
15.2
0.21
11
56
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
181
864
2.11
19.61
1.3
1.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
433
2709
1.62
19.59
1.3
1.3
u/ml
38.8
40.9
0.04
19
173
(3011397) Hemoglobin [Presence] in Urine by Test strip
2585
21798
1.24
19.38
3.2
3.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
400
2463
1.65
19.29
1.3
1.3
u/ml
1.5
4.1
1.42
27
259
(1616796) Gas panel - Central venous blood
77
2105
0.36
18.98
2.7
3.7
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
40
1535
0.26
18.88
1.9
1.9
mmol/l
1.6
1.7
0.21
40
1502
(3048689) Calprotectin [Mass/mass] in Stool
1438
11328
1.31
18.73
2.2
2.3
ug/g
119.9
134.5
0.83
1036
8866
(3003327) Ova and parasites identified in Stool by Light microscopy
471
3077
1.55
17.75
2.0
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
982
7389
1.36
17.45
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
237
1298
1.84
17.34
1.1
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
737
5295
1.42
17.28
1.6
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
618
4307
1.46
17.08
2.0
1.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
224
1214
1.86
16.95
1.5
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
224
1218
1.86
16.78
1.5
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
1355
10737
1.30
16.78
1.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
225
1227
1.85
16.71
1.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
223
1217
1.85
16.52
1.5
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
40
91
4.41
16.31
1.1
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
226
1246
1.83
16.22
1.5
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
222
1221
1.84
16.06
1.5
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
59
1683
0.35
15.98
2.1
3.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
113
485
2.34
15.95
1.1
1.1
u/l
1.1
1.1
0.19
54
228
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
186
976
1.92
15.58
1.6
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
937
7127
1.34
15.47
2.6
2.7
g/l
10.5
10.5
0.28
876
6535
(3030981) Hyaline casts [#/volume] in Urine by Automated count
301
4815
0.61
15.37
1.8
2.7
e6/l
0.3
0.3
0.02
288
4686
(3038026) Centromere Ab [Units/volume] in Serum
157
781
2.03
15.34
1.3
1.2
u/ml
44.6
54.9
—
6
38
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
4358
39318
1.18
15.20
2.2
2.3
nmol/l
79.9
77.9
4.73
3685
35414
(1761482) Bacteria [#/volume] in Urine by Culture
107
2319
0.46
15.14
3.9
4.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
108
2328
0.46
15.06
2.0
3.2
mmol/l
24.6
24.9
0.37
95
2036
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
236
1355
1.76
14.83
1.1
1.1
au/ml
11.9
11.7
0.01
14
73
(4027681)
115
514
2.25
14.80
1.1
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
225
1276
1.78
14.75
1.3
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
508
3510
1.47
14.69
1.6
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
2547
29312
0.83
14.68
3.6
4.0
mg/mmol
8.0
9.1
0.27
1418
18171
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
152
760
2.01
14.66
1.3
1.2
u/ml
87.0
64.5
—
6
37
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
39
95
4.12
14.60
1.1
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
147
728
2.03
14.56
1.3
1.2
u/ml
2.3
5.4
—
10
47
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
152
764
2.00
14.46
1.3
1.2
u/ml
15.5
41.4
—
8
59
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1873
15680
1.24
14.44
1.5
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1126
8880
1.30
14.35
2.3
2.5
u/l
33.7
44.0
1.17
959
7591
(3022621) pH of Urine by Test strip
807
6069
1.36
14.34
2.8
3.0
—
—
—
0
0
(3044889) 12 lead EKG panel
6165
65841
0.85
14.28
3.5
3.8
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
38
93
4.10
14.15
1.1
1.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
414
2771
1.51
14.02
2.7
2.2
g/l
38.8
37.8
2.43
340
2388
(42529406) Shigella sp [Presence] in Stool by Culture
398
2650
1.52
13.82
1.2
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
37
91
4.08
13.69
1.1
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
396
2642
1.52
13.62
1.1
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
375
2479
1.53
13.47
2.7
2.3
g/l
0.0
0.0
0.63
326
2259
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
392
2618
1.52
13.42
1.1
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
38
1234
0.31
13.41
1.9
1.8
%
90.3
89.7
0.26
38
1216
(3019150) Specific gravity of Urine by Refractometry
1676
19948
0.81
13.40
3.6
4.2
kg/l
1.0
1.0
0.33
278
3002
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
38
97
3.93
13.38
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
141
712
1.99
13.28
1.2
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
442
3034
1.48
13.24
2.7
2.4
g/l
1.0
0.9
0.35
368
2613
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
140
706
2.00
13.24
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
140
706
2.00
13.24
1.2
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
99
439
2.27
13.04
1.1
1.1
u/ml
5.6
6.9
0.20
16
71
(3021960) Folate [Moles/volume] in Serum or Plasma
2478
21511
1.20
13.04
1.5
1.5
nmol/l
21.9
20.6
4.02
1973
18367
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
140
710
1.98
13.03
1.2
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2376
20555
1.20
12.97
1.3
1.3
u/ml
1.5
1.8
0.56
438
5504
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
3202
28436
1.18
12.93
2.1
2.2
u/l
161.7
211.9
4.33
2986
26618
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
494
3482
1.44
12.89
1.7
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
101
2104
0.48
12.86
2.8
3.3
kpa
8.2
8.2
0.07
95
1949
(3023420) DNA double strand Ab [Units/volume] in Serum
182
1014
1.81
12.72
1.8
1.5
iu/ml
28.2
29.5
0.08
16
48
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
139
710
1.97
12.69
1.2
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
394
2669
1.49
12.62
2.8
2.2
g/l
0.0
0.0
0.10
343
2444
(40759836) Histone Ab [Presence] in Serum by Immunoblot
138
705
1.97
12.60
1.2
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
169
927
1.84
12.44
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
98
442
2.23
12.42
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2369
20570
1.19
12.33
1.7
1.8
mg/l
1.0
1.2
1.41
1737
15746
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
165
902
1.84
12.29
1.7
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
428
2964
1.46
12.28
1.6
1.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
557
4052
1.39
12.17
1.8
2.0
u/l
42.4
39.2
3.23
477
3580
(3017446) Testosterone [Moles/volume] in Serum or Plasma
764
5845
1.33
12.10
2.2
2.2
nmol/l
13.2
12.6
1.30
671
5146
(3000034) Microalbumin [Mass/volume] in Urine
21
899
0.23
12.07
3.7
3.1
mg/l
138.2
52.4
0.35
13
659
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
363
2441
1.50
12.07
2.8
2.3
g/l
0.0
0.0
0.00
324
2251
(3002385) Erythrocyte distribution width [Ratio]
7329
76861
0.86
12.04
16.3
17.5
%
13.6
13.7
8.09
7218
75283
(3017732) Neutrophils [#/volume] in Blood
843
6565
1.31
11.76
2.6
3.0
e9/l
3.8
4.1
2.01
531
5100
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
116
572
2.04
11.73
1.1
1.1
iu/ml
10.0
10.1
0.01
27
131
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2911
25825
1.17
11.65
5.7
4.9
ug/l
2.6
3.2
1.06
2539
23219
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
8882
85695
1.20
11.63
5.5
5.8
mmol/mol
38.5
39.7
43.03
7896
79328
(3019897) Erythrocyte distribution width [Ratio] by Automated count
38
1144
0.33
11.63
2.6
2.8
%
13.0
13.2
0.89
38
1128
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
1032
8276
1.27
11.46
2.0
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
1493
12483
1.23
11.44
1.3
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
107
519
2.07
11.32
1.4
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
340
2290
1.50
11.24
1.7
1.6
e6/l
11058.3
13478.6
0.62
246
1637
(3003396) Base excess in Arterial blood by calculation
837
10575
0.77
11.12
6.8
7.4
mmol/l
0.6
1.1
3.38
718
8344
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
162
2783
0.58
11.07
1.4
1.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
678
8795
0.76
10.99
7.7
8.2
g/l
121.2
121.0
0.07
672
8471
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
25
54
4.64
10.92
1.5
1.5
%
11.7
39.3
2.89
20
33
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
591
7807
0.74
10.89
2.1
2.8
ng/l
156.4
180.2
1.28
534
7126
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
7583
72383
1.16
10.64
4.2
4.1
pmol/l
14.7
14.8
4.22
6662
65947
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
451
3240
1.41
10.64
1.6
1.7
mg/l
2.9
3.6
1.24
321
2286
(3016502) Oxygen saturation in Arterial blood
745
9500
0.77
10.62
7.2
7.8
%
95.9
95.7
0.39
740
9144
(3008898) HLA-B27 [Presence]
422
2999
1.42
10.59
1.1
1.1
—
—
—
0
0
(4146454)
172
998
1.74
10.55
2.9
2.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
554
4131
1.36
10.43
3.1
3.7
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
850
10612
0.78
10.22
6.7
7.4
kpa
5.1
5.1
0.02
821
10145
(3027801) Oxygen [Partial pressure] in Arterial blood
850
10610
0.78
10.20
6.7
7.4
kpa
13.3
12.4
4.48
822
10137
(3022217) INR in Platelet poor plasma by Coagulation assay
1409
11860
1.22
10.03
24.4
23.8
inr
1.2
1.3
2.04
103
1757
(46235355) HIV 1 and 2 tests - Meaningful Use set
1701
14591
1.20
9.90
1.7
1.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
106
542
1.97
9.76
1.2
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
511
3804
1.36
9.74
1.9
2.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
363
5090
0.70
9.74
8.8
9.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
5058
47121
1.14
9.72
5.4
6.8
mmol/l
1.2
1.2
20.31
4464
39714
(4015189)
62
256
2.43
9.71
1.6
2.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
459
3369
1.38
9.57
2.6
2.3
g/l
3.0
3.1
0.73
350
2619
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
67
289
2.33
9.53
2.8
3.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
136
765
1.79
9.34
1.1
1.1
—
31.9
—
0
8
(3012516) Albumin [Mass/volume] in Urine
2493
27903
0.86
9.34
3.1
3.3
mg/l
190.6
444.1
3.24
1399
17274
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
918
7441
1.26
9.30
1.9
1.9
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
49
186
2.64
9.15
1.1
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
52
1214
0.43
9.12
2.6
2.1
pg
33.3
32.7
0.50
52
1205
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
946
7715
1.25
9.08
1.7
1.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
402
5474
0.72
9.05
2.2
3.5
g/l
131.9
128.8
2.39
396
5336
(3026493) Urate [Moles/volume] in Serum or Plasma
2746
24640
1.15
9.04
2.4
2.6
umol/l
5171.3
4370.6
0.41
2271
21316
(3015377) Calcium [Moles/volume] in Serum or Plasma
3494
31893
1.14
8.96
3.2
3.5
mmol/l
2.4
2.4
5.37
2724
27839
(3019832) Treponema pallidum Ab [Presence] in Serum
826
6649
1.26
8.88
1.6
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
450
3335
1.36
8.86
2.6
2.7
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
434
3213
1.37
8.61
1.5
1.6
titre
595.4
260.8
0.61
12
140
(3026782) Osmolality of Urine
1576
18164
0.85
8.46
2.4
2.8
mosm/kgh2o
545.4
540.5
0.38
1242
15495
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
608
4742
1.30
8.42
1.1
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
401
2942
1.38
8.42
1.8
1.6
g/l
1.2
1.2
2.05
373
2783
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
117
653
1.80
8.30
2.4
2.6
e6/l
628.7
700.4
0.66
65
273
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
290
2017
1.45
8.27
1.2
1.3
u/ml
38.3
46.5
0.29
21
206
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
105
1863
0.56
8.19
1.7
3.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1276
10842
1.20
8.17
2.7
2.7
umol/l
7.0
8.1
1.45
1127
9397
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
104
563
1.86
8.15
1.1
1.1
nmol/l
4.2
9.1
0.66
30
110
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
196
2979
0.65
8.09
1.5
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
2682
29620
0.87
8.06
3.0
3.2
mmol/l
7.5
7.4
0.87
2081
24855
(40768797) Stomach Pathology biopsy report
1552
13433
1.18
8.05
1.3
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
444
3339
1.34
7.98
2.6
2.3
g/l
10.0
10.2
0.52
364
2800
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
472
3584
1.33
7.95
2.6
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
472
3587
1.33
7.91
2.6
2.3
g/l
7.1
7.4
3.50
369
2686
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
386
2860
1.36
7.66
1.8
1.7
g/l
0.2
0.2
1.27
356
2700
(3045683) HLA typing for celiac disease panel - Blood or Tissue
98
532
1.85
7.64
1.0
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
351
2566
1.38
7.58
1.9
2.0
mg/l
12.1
11.3
0.66
314
2388
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
217
1452
1.50
7.55
1.2
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
468
3578
1.32
7.53
2.6
2.3
g/l
3.7
3.8
0.73
344
2558
(3035350) Ketones [Presence] in Urine by Test strip
4275
45740
0.89
7.50
3.2
3.7
estimate
0.0
0.0
1.28
396
8562
(36304419) Bacteria [Presence] in Urine
2773
25168
1.14
7.48
3.1
3.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
188
1225
1.54
7.41
1.1
1.1
u/ml
1.9
3.4
2.25
60
561
(40761535) Cells panel - Urine sediment
917
7630
1.22
7.29
3.3
3.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
179
1165
1.55
7.11
1.1
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
522
4093
1.29
6.99
1.4
1.6
u/ml
14.4
15.1
0.04
12
114
(3021589) Normoblasts [#/volume] in Blood
3877
41599
0.89
6.98
8.1
9.8
e9/l
0.0
0.0
2.04
2949
34028
(1002224) Polysomnography panel
466
3604
1.31
6.93
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
633
5104
1.26
6.75
1.4
1.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
52
1075
0.48
6.70
1.6
2.3
mmol/l
4.1
4.0
0.04
52
1061
(3035285) Chloride [Moles/volume] in Venous blood
52
1075
0.48
6.70
1.6
2.3
mmol/l
105.9
105.4
0.33
52
1061
(3000494) Fungus identified in Specimen by Culture
1298
11239
1.18
6.66
1.4
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
127
778
1.64
6.55
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
555
4428
1.27
6.49
1.4
1.4
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
16
37
4.33
6.48
1.0
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
300
2201
1.37
6.40
1.7
1.8
nmol/l
45.9
41.6
2.23
288
2122
(3040151) Glucose [Moles/volume] in Capillary blood
49
1016
0.48
6.39
1.9
12.5
mmol/l
7.5
7.2
0.17
36
851
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
98
564
1.74
6.38
1.3
1.3
pmol/l
38.4
117.4
0.87
35
177
(3029075) Extractable nuclear Ab panel - Serum
55
261
2.11
6.35
1.1
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
52
1052
0.49
6.32
1.6
2.3
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
40
167
2.40
6.25
2.4
2.3
ug/l
3.0
3.9
0.85
17
59
(3021447) Carbon dioxide [Partial pressure] in Venous blood
693
8376
0.82
6.19
2.9
4.1
kpa
5.8
5.8
0.19
673
8139
(3006576) Bicarbonate [Moles/volume] in Blood
7
315
0.22
6.10
5.9
6.6
mmol/l
26.5
25.0
—
7
287
(3006184) Hemoglobin [Mass/volume] in Capillary blood
141
2154
0.65
6.07
1.8
2.2
g/l
133.8
129.0
1.42
67
1535
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
45
202
2.23
5.98
1.1
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
14
31
4.52
5.97
1.0
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
2269
20593
1.13
5.94
4.3
4.3
%
21.7
21.8
0.11
1117
10125
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
613
5002
1.24
5.91
2.5
2.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
694
8347
0.82
5.90
2.9
4.1
mmol/l
1.5
1.9
2.40
579
6833
(3021788) Differential panel - Synovial fluid
242
1742
1.40
5.83
1.5
1.5
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
77
425
1.82
5.80
1.1
1.1
iu/ml
3.5
3.7
—
6
24
(3020779) Urea [Moles/volume] in Serum or Plasma
684
8214
0.82
5.73
5.2
7.6
mmol/l
8.4
9.6
5.57
640
7842
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
48
227
2.12
5.64
1.2
1.2
pmol/l
264.3
293.1
0.33
27
166
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
51
997
0.51
5.64
1.4
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
152
1012
1.51
5.54
3.6
4.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
32
732
0.44
5.51
1.4
1.5
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
177
1219
1.46
5.47
1.2
1.3
u/ml
48.6
61.6
—
5
101
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
154
2253
0.68
5.39
2.3
2.4
ug/min
98.6
99.0
0.00
88
1351
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
204
1447
1.42
5.38
1.5
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
182
1265
1.45
5.37
1.1
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
204
1449
1.42
5.34
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
204
1453
1.41
5.27
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
204
1454
1.41
5.25
1.5
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
181
1266
1.44
5.18
1.1
1.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
100
615
1.63
5.17
2.4
2.6
e9/l
0.2
0.2
0.67
88
529
(3048929) Epstein Barr virus Ab [Presence] in Serum
338
2612
1.30
5.16
1.2
1.2
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
27
103
2.63
5.13
1.0
1.1
u/ml
0.1
0.4
0.44
20
65
(3001122) Ferritin [Mass/volume] in Serum or Plasma
4175
39392
1.10
5.11
2.8
2.9
ug/l
116.9
129.9
2.62
3772
36462
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
75
1267
0.59
5.05
1.2
1.3
mmol/l
6.7
7.4
1.15
55
936
(3004775) Volume in Urine collected for unspecified duration
36
760
0.47
5.04
2.7
2.3
ml
641.6
648.1
0.04
30
523
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
327
2530
1.30
4.96
1.5
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
15
457
0.33
4.96
1.7
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
765
6499
1.19
4.94
1.2
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
2792
25868
1.11
4.93
3.2
3.2
e6/l
0.3
0.4
4.60
1933
19428
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
90
1437
0.62
4.82
1.4
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
44
215
2.05
4.80
1.6
1.6
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
130
866
1.51
4.79
1.5
1.4
e6/l
53906.9
129484.0
1.28
90
585
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
76
1261
0.60
4.79
1.4
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
80
1307
0.61
4.73
1.4
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
2639
28437
0.90
4.68
2.7
3.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
71
1190
0.59
4.67
2.0
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
67
381
1.76
4.66
2.0
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
67
381
1.76
4.66
2.0
2.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
101
641
1.58
4.64
2.3
2.5
e6/l
443.6
517.2
1.07
87
535
(3021601) Nitrite [Presence] in Urine by Test strip
4364
45928
0.92
4.63
4.5
5.0
estimate
0.0
0.0
1.60
401
8718
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
48
246
1.96
4.61
1.5
1.5
ug/l
0.4
0.4
0.32
27
156
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
76
450
1.69
4.59
1.4
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
76
450
1.69
4.59
1.4
1.4
—
—
—
0
0
(44806420)
6
250
0.24
4.58
2.5
2.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
595
0.44
4.56
1.4
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1072
12153
0.87
4.50
4.2
6.0
mmol/l
1.0
1.0
2.90
979
11331
(3005011) Chlamydia sp Ab [Titer] in Serum
30
129
2.33
4.48
1.8
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
21
519
0.40
4.46
1.5
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
67
387
1.74
4.43
2.0
2.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2868
30696
0.91
4.37
3.0
3.3
u/l
31.2
34.6
3.46
2718
29074
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
227
1701
1.34
4.37
1.9
1.7
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
31
137
2.27
4.36
1.0
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
31
137
2.27
4.36
1.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
31
137
2.27
4.36
1.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
136
939
1.45
4.25
1.6
1.7
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
8
271
0.29
4.21
1.3
1.4
%
1.7
2.5
—
8
231
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
79
1256
0.63
4.21
1.6
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
23
527
0.44
4.09
1.4
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
291
3681
0.78
4.03
2.0
2.0
ug/l
0.9
2.2
5.00
251
3278
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
476
5707
0.83
4.00
6.9
7.3
mmol/l
25.0
24.8
0.68
476
5669
(3044242) Glucose [Moles/volume] in Arterial blood
19
465
0.41
3.98
1.8
2.0
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
9
14
6.43
3.98
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
52
289
1.80
3.96
1.1
1.1
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
10
331
0.30
3.96
1.5
1.4
%
60.3
63.6
—
10
273
(3001019) Free T4 and TSH panel - Serum or Plasma
532
4472
1.20
3.92
1.7
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
24
531
0.45
3.91
1.4
1.6
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
40
205
1.95
3.90
1.1
1.1
—
456.0
—
0
10
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
22
502
0.44
3.89
14.6
12.5
nmol/l
795.4
832.3
0.13
22
478
(3003434) Protein [Mass/volume] in Pleural fluid
75
1182
0.63
3.88
1.4
1.5
g/l
33.5
33.1
0.10
67
1066
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
23
514
0.45
3.86
15.0
17.9
nmol/l
1381.0
3286.4
0.52
23
499
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
65
2.77
3.84
1.1
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
90
585
1.54
3.80
1.3
1.5
u/l
6.0
6.4
0.27
73
490
(4035726)
987
8742
1.14
3.76
1.4
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
65
393
1.66
3.71
1.1
1.1
miu/ml
1621.2
1558.1
0.15
65
393
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
93
613
1.52
3.70
1.5
1.2
—
—
—
0
0
(3020891) Body temperature
297
3704
0.80
3.67
4.6
4.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
5103
49021
1.08
3.63
5.9
6.3
umol/l
11.0
11.2
0.40
4762
46531
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
92
608
1.52
3.62
1.5
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
588
6856
0.85
3.62
2.3
3.4
kpa
4.6
4.6
0.02
571
6639
(3032080) INR in Blood by Coagulation assay
3562
37527
0.92
3.60
6.2
8.8
inr
1.2
1.2
1.10
520
10865
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
131
1823
0.72
3.60
1.3
1.8
nmol/l
0.8
0.8
0.34
110
1530
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
889
10038
0.88
3.54
1.7
1.8
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
10
26
3.85
3.52
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
117
817
1.44
3.51
1.3
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
270
2141
1.27
3.50
1.5
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
22
479
0.46
3.48
1.1
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
40
214
1.87
3.47
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
723
6303
1.16
3.47
1.2
1.2
iu/ml
176.0
143.7
0.97
222
2358
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
109
1554
0.70
3.46
1.5
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
246
3112
0.79
3.46
2.7
3.2
u/ml
0.4
0.3
0.21
138
1798
(3028433) Virus identified in Specimen by Culture
55
325
1.70
3.44
1.3
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
110
1563
0.70
3.43
1.6
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1866
17234
1.10
3.41
2.9
3.1
mmol/l
2.4
2.5
3.64
1594
15123
(3051387) C reactive protein [Mass/volume] in Capillary blood
145
1963
0.74
3.38
3.3
3.6
mg/l
30.4
26.1
0.25
41
1214
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
119
1658
0.71
3.33
1.4
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1818
19641
0.91
3.28
2.4
2.6
e6/l
4.8
5.7
1.87
1535
17166
(3024891) Influenza virus A+B Ag [Presence] in Specimen
280
2249
1.25
3.28
1.1
1.1
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
8
240
0.33
3.28
1.3
1.4
%
42.0
22.6
—
8
217
(3025130) Human papilloma virus identified in Specimen
159
1185
1.35
3.28
1.5
1.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
47
270
1.74
3.27
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
66
1024
0.64
3.25
1.6
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
203
1570
1.30
3.23
1.6
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
53
863
0.61
3.23
1.5
1.5
%
34.7
31.4
0.32
41
503
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
332
2722
1.23
3.23
1.2
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
198
1531
1.30
3.17
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
346
2855
1.22
3.17
2.8
3.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
138
1013
1.37
3.15
1.4
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
158
1185
1.34
3.14
1.5
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
50
296
1.69
3.14
1.5
1.2
%
106.7
112.5
0.86
44
256
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
180
1377
1.31
3.12
1.2
1.2
u/ml
3.4
4.2
0.80
84
594
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
349
2887
1.22
3.12
1.6
1.6
iu/ml
0.4
8.9
0.87
73
630
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
235
1862
1.27
3.11
1.1
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
95
656
1.45
3.08
1.4
1.8
mmol/l
6.3
6.7
1.04
82
456
(3004588) Protein electrophoresis panel - Serum or Plasma
729
6420
1.15
3.07
2.6
2.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
158
1190
1.33
3.06
1.5
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
103
724
1.43
3.04
1.1
1.0
mg/l
294.2
289.1
0.26
93
645
(3013005) Retinol [Moles/volume] in Serum or Plasma
61
384
1.59
3.03
1.5
1.6
umol/l
2.0
2.0
0.04
54
357
(3043410) Blood group antigens tested for on Red Blood Cells
9
245
0.37
3.02
1.8
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
112
800
1.40
3.02
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
282
2292
1.24
3.00
1.4
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
20
87
2.30
3.00
1.1
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
74
489
1.52
2.98
1.9
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
74
489
1.52
2.98
1.9
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
74
489
1.52
2.98
1.9
1.9
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
19
81
2.35
2.98
2.3
2.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
132
973
1.36
2.96
3.3
3.4
%
56.3
58.1
0.43
97
630
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
56
348
1.61
2.94
1.1
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
118
855
1.38
2.94
1.2
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
74
491
1.51
2.93
1.9
1.9
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
20
88
2.28
2.93
1.0
1.1
—
—
—
0
0
(3024316) Viscosity of Plasma
13
46
2.83
2.91
1.1
1.5
mpas
1.5
1.6
—
7
26
(3044941) Cell count panel - Synovial fluid
187
1454
1.29
2.90
1.4
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
55
342
1.61
2.89
2.1
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
23
456
0.50
2.85
2.2
2.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
174
0.29
2.81
1.0
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
41
238
1.73
2.80
1.1
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
28
144
1.95
2.79
1.2
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
41
239
1.72
2.76
1.0
1.0
u/ml
6.2
8.4
—
8
31
(3018095) Leukocytes [#/volume] in Urine
3452
32940
1.07
2.76
3.7
3.7
e6/l
66.6
98.6
2.29
2187
23231
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
35
605
0.58
2.75
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
83
1185
0.70
2.74
2.5
2.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
109
791
1.38
2.72
1.9
2.2
%
43.2
42.5
0.06
29
99
(3022689) Creatine [Moles/volume] in Urine
12
298
0.40
2.72
1.8
1.5
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
29
526
0.55
2.72
1.2
1.3
mmol/l
5.7
5.8
0.39
29
494
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
378
3197
1.19
2.71
1.8
2.3
ug/l
170.8
563.4
5.86
342
3011
(3043238) Trisomy 21 risk [Likelihood] in Fetus
160
1231
1.30
2.71
1.5
1.5
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
14
54
2.59
2.70
1.1
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
15
60
2.50
2.69
1.1
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
196
2462
0.79
2.68
2.6
3.6
mg/l
1.3
1.5
7.26
179
2263
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
85
592
1.44
2.68
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
524
4558
1.16
2.66
2.1
1.9
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
494
4279
1.16
2.66
1.1
1.1
titre
160.8
197.8
0.20
12
110
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
231
0.39
2.65
1.1
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
9
233
0.39
2.64
3.3
1.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
132
993
1.33
2.63
1.1
1.1
%
97.3
95.8
0.30
120
928
(3044927) Protein electrophoresis panel - Urine
125
933
1.34
2.63
1.2
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
20
93
2.15
2.60
2.4
2.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
18
80
2.25
2.60
1.2
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
25
127
1.97
2.59
1.2
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
169
1319
1.29
2.59
1.1
1.1
u/ml
1.7
2.0
0.10
40
311
(3014271) Vancomycin [Susceptibility]
65
433
1.50
2.57
2.6
2.9
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
41
245
1.68
2.55
1.0
1.3
nmol/l
155.6
123.3
0.68
27
183
(3034988) Calcium [Moles/volume] in Capillary blood
6
179
0.33
2.52
1.2
2.2
mmol/l
1.2
1.2
—
6
174
(40757373) Influenza virus identified in Isolate
6
180
0.33
2.52
1.0
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
24
449
0.53
2.52
3.8
3.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
417
3584
1.17
2.50
2.0
1.8
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
97
1325
0.73
2.50
4.5
5.1
umol/l
362.8
366.9
0.11
77
1145
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
82
576
1.43
2.50
1.3
1.3
titre
32.0
59.8
—
5
52
(3050129) First trimester maternal screen panel - Serum or Plasma
220
1782
1.24
2.48
1.5
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
298
2491
1.20
2.47
1.1
1.1
u/ml
3.2
7.4
1.66
37
289
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
84
594
1.42
2.47
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
202
1622
1.25
2.47
1.1
1.1
u/ml
2.3
1.4
0.36
85
638
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
29
158
1.84
2.47
1.4
1.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
195
1560
1.25
2.46
1.6
1.5
g/l
0.7
0.8
0.32
159
1175
(3026250) Tacrolimus [Mass/volume] in Blood
21
406
0.52
2.46
39.3
34.9
ug/l
7.0
7.3
0.48
21
368
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
103
755
1.37
2.46
1.1
1.2
titre
102.9
180.4
1.69
17
142
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
165
1296
1.28
2.43
1.4
1.4
u/l
29.6
30.7
0.14
131
1063
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
205
0.39
2.40
1.4
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
142
1096
1.30
2.40
1.1
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
178
1415
1.26
2.38
1.6
1.6
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
198
1594
1.25
2.38
1.9
1.9
pmol/l
207.8
200.2
0.45
182
1495
(3006922) Hepatitis E virus Ab [Presence] in Serum
89
641
1.39
2.37
1.1
1.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
59
393
1.50
2.36
1.2
1.3
umol/l
4.3
4.2
0.12
52
365
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
13
52
2.50
2.35
1.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
14
306
0.46
2.35
3.0
3.7
%
44.7
52.9
0.71
14
294
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
49
314
1.56
2.34
1.7
1.2
g/l
0.3
0.3
0.16
39
248
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
97
1309
0.74
2.33
1.4
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2747
26145
1.07
2.32
2.7
2.9
ng/l
796.1
1264.8
17.76
2192
22502
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
548
4836
1.14
2.31
7.8
9.5
mmol/l
24.5
24.3
0.88
512
4530
(3014111) Lactate [Moles/volume] in Serum or Plasma
885
8039
1.11
2.30
5.8
7.2
mmol/l
1.3
1.3
0.23
851
7758
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
980
8950
1.10
2.29
2.5
2.3
g/l
0.2
0.2
6.28
905
8344
(3023199) Leukocytes [#/volume] in Pleural fluid
75
1051
0.71
2.29
1.4
1.5
e6/l
3927.0
2789.9
0.24
45
760
(3020630) Protein [Mass/volume] in Serum or Plasma
854
7746
1.11
2.28
2.6
2.6
g/l
67.0
66.5
1.28
740
7055
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
179
2223
0.80
2.27
1.7
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
219
1795
1.22
2.25
1.2
1.2
—
—
—
0
0
(4306422)
173
1382
1.26
2.24
1.2
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
122
932
1.31
2.24
2.2
2.3
e9/l
1.1
1.2
0.07
44
572
(3023430) Cat dander IgE Ab [Units/volume] in Serum
135
1048
1.29
2.21
1.1
1.1
u/ml
3.7
3.7
0.00
52
412
(3045788) Cell count panel - Pleural fluid
55
809
0.68
2.21
1.5
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
20
377
0.53
2.19
3.3
2.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
4489
46369
0.95
2.19
3.3
3.7
estimate
0.0
0.0
2.66
392
8523
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
167
1333
1.26
2.19
1.1
1.1
%
124.5
117.3
1.69
144
1189
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
210
0.43
2.18
1.7
2.4
—
—
—
0
0
(44790047)
74
1029
0.72
2.17
1.6
1.5
—
—
—
0
0
(44790048)
74
1029
0.72
2.17
1.6
1.5
—
—
—
0
0
(44806118)
74
1029
0.72
2.17
1.6
1.5
—
—
—
0
0
(44790049)
74
1029
0.72
2.17
1.6
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
617
5513
1.13
2.16
3.0
3.6
mmol/l
1.4
1.8
2.26
476
4114
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
174
2153
0.81
2.16
1.8
1.6
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
64
443
1.45
2.15
3.5
5.0
u/ml
16795.1
9316.8
—
7
74
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
309
2631
1.18
2.13
2.4
2.6
%
183.2
192.5
1.14
292
2495
(4268621)
124
958
1.30
2.12
2.2
2.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2333
24551
0.94
2.11
3.7
4.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1809
17024
1.08
2.11
1.6
1.7
nmol/l
1049.5
1168.7
6.04
1206
12892
(3022475) Manganese [Moles/volume] in Blood
15
68
2.21
2.10
1.0
1.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
15
68
2.21
2.10
4.9
6.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
12
49
2.45
2.10
1.1
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
121
934
1.30
2.09
1.1
1.0
u/ml
0.7
0.4
0.35
25
210
(3000330) Specific gravity of Urine by Test strip
523
4637
1.13
2.09
2.8
3.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
134
1049
1.28
2.08
1.3
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
97
1283
0.75
2.07
2.8
2.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
860
7849
1.10
2.06
1.4
1.4
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
56
0.00
2.06
0.0
3.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
235
0.43
2.05
5.3
7.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
174
1409
1.24
2.04
1.2
1.2
u/ml
2.3
3.5
1.23
56
459
(4010399)
779
7080
1.11
2.03
1.4
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
919
10014
0.91
2.03
1.6
1.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
142
1124
1.27
2.02
1.1
1.1
u/ml
3.1
4.0
0.21
50
426
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
221
1836
1.21
2.02
1.2
1.4
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
12
50
2.40
2.02
1.1
1.0
u/ml
0.0
0.4
—
7
31
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
16
76
2.11
2.02
1.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
178
0.39
2.01
2.6
2.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
95
1251
0.76
1.98
4.7
6.7
mg/l
10.4
11.7
2.54
84
1158
(3003888) Timothy IgE Ab [Units/volume] in Serum
180
1469
1.23
1.97
1.1
1.1
u/ml
4.1
4.8
0.31
94
722
(4094501)
298
2549
1.17
1.97
1.1
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
35
217
1.61
1.96
1.3
1.3
mu/l
61.3
71.2
0.10
22
165
(3000492) Spirometry study
957
8812
1.09
1.92
1.5
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
172
1403
1.23
1.90
1.1
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
360
4124
0.87
1.90
2.1
3.0
%
0.6
0.7
2.78
344
3949
(3019174) dRVVT (LA screen)
17
85
2.00
1.89
1.2
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
22
121
1.82
1.87
1.1
1.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
53
0.00
1.86
0.0
3.2
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
53
0.00
1.86
0.0
12.8
—
325.0
—
0
43
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
64
457
1.40
1.86
1.2
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
43
284
1.52
1.86
1.1
1.1
%
85.1
88.3
0.20
17
127
(3015171) Extractable nuclear Ab [Units/volume] in Serum
439
3883
1.14
1.85
1.3
1.3
u/ml
0.2
1.1
4.68
41
353
(3028026) IgM [Mass/volume] in Serum or Plasma
619
5589
1.11
1.85
1.7
1.9
g/l
1.4
1.3
0.31
556
5110
(3033799) Differential panel - Peritoneal fluid
16
304
0.53
1.85
2.3
2.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
6
17
3.53
1.83
1.0
3.6
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
16
303
0.53
1.83
2.2
2.0
e6/l
2104.4
15764.4
—
8
164
(3007853) Bacteria identified in Skin by Aerobe culture
1024
11046
0.92
1.82
1.6
1.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
110
857
1.29
1.82
1.1
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
50
717
0.70
1.81
1.6
1.4
promille
1.2
1.2
0.05
39
548
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
104
805
1.29
1.80
1.8
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
104
805
1.29
1.80
1.8
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
104
805
1.29
1.80
1.8
1.7
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
33
513
0.64
1.79
1.7
1.4
nmol/l
1.1
1.2
0.18
20
401
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1460
15524
0.93
1.79
2.7
3.4
mmol/l
0.8
0.8
4.28
1330
14521
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
17
87
1.96
1.79
1.5
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
717
6542
1.10
1.77
1.3
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
32
200
1.60
1.76
1.2
1.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
14
67
2.09
1.75
1.1
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
328
2857
1.15
1.75
1.3
1.4
ug/g
299.6
274.0
1.61
192
1667
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
79
591
1.34
1.75
1.4
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
211
2501
0.84
1.75
2.3
2.1
u/l
5198.3
4558.3
0.13
85
959
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
6
18
3.33
1.74
1.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
32
201
1.59
1.73
1.9
1.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
34
217
1.57
1.72
1.1
1.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
48
331
1.45
1.71
1.6
1.9
u/ml
374.9
41988.8
—
8
44
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
68
500
1.36
1.69
1.2
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
44
299
1.47
1.69
1.3
1.2
g/l
39.4
38.6
0.11
14
158
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
59
424
1.39
1.68
1.1
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
630
5727
1.11
1.68
3.0
3.6
ph
7.4
7.4
0.13
17
772
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1891
17964
1.06
1.68
3.5
3.7
ng/l
365.8
481.7
0.53
1444
13838
(3024869) Neuronal Ab [Presence] in Serum
31
195
1.59
1.67
1.0
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
21
119
1.77
1.65
1.0
1.1
u/ml
0.1
2.3
—
5
29
(40768446) Kidney Pathology biopsy report
22
368
0.60
1.65
1.2
1.6
—
—
—
0
0
(3048879) Bone marrow aspiration report
40
268
1.49
1.65
1.9
1.9
—
—
—
0
0
(3036489) Thrombin time
392
3474
1.13
1.64
1.9
2.1
s
21.3
21.6
0.30
342
3013
(3017143) Hepatitis C virus Ab [Presence] in Serum
1085
10119
1.08
1.64
1.5
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
40
269
1.49
1.62
1.1
1.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
12
56
2.14
1.60
1.1
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
170
1414
1.21
1.60
1.1
1.1
u/ml
0.8
1.1
0.44
76
585
(3028308) Erythrocytes [#/volume] in Pleural fluid
71
940
0.75
1.60
1.4
1.5
e6/l
38634.1
59958.6
0.61
33
553
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
134
0.37
1.60
9.2
11.7
mmol/l
5.2
5.3
—
5
134
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
94
732
1.29
1.60
1.2
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
96
752
1.28
1.56
1.2
1.1
nmol/l
377.6
360.1
0.36
89
637
(40768806) Pleura Pathology biopsy report
72
947
0.76
1.56
1.5
1.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
65
482
1.35
1.56
1.8
1.7
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
207
0.48
1.53
5.3
7.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
79
605
1.31
1.53
1.4
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1377
14582
0.94
1.52
2.2
2.6
umol/l
14.3
13.0
9.34
1271
13505
(40768800) Prostate Pathology biopsy report
193
1634
1.18
1.52
1.2
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
4512
43954
1.05
1.51
3.3
4.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
7
27
2.59
1.51
1.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
69
908
0.76
1.51
1.4
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
110
882
1.25
1.49
2.2
2.0
umol/l
5.7
7.4
0.87
84
639
(3042733) HLA Ab [Presence] in Serum
17
294
0.58
1.48
3.6
4.9
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
72
548
1.32
1.47
1.4
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
116
938
1.24
1.47
2.3
2.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
28
428
0.65
1.46
3.3
3.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
660
6062
1.09
1.46
2.9
3.4
pmol/l
4.5
4.5
0.25
570
5388
(4198724)
22
355
0.62
1.46
1.7
2.3
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
7
28
2.50
1.45
1.0
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
7
28
2.50
1.45
1.3
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
632
5798
1.10
1.44
3.0
3.6
kpa
5.1
5.2
1.80
581
5371
(3020123) Porphyrins [Interpretation] in Serum or Plasma
11
52
2.12
1.44
1.0
1.1
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
37
532
0.69
1.43
2.2
2.2
umol/l
48.3
25.8
—
5
50
(3034770) Mitochondria Ab [Titer] in Serum
303
2671
1.14
1.42
1.3
1.2
titre
757.5
896.1
—
8
94
(3023487) Leukocytes [#/volume] in Peritoneal fluid
21
340
0.62
1.42
2.1
2.2
e6/l
865.4
3130.7
0.48
14
234
(3051593) INR in Capillary blood by Coagulation assay
56
413
1.36
1.42
1.1
10.4
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
40
278
1.44
1.41
1.1
1.2
%
84.9
89.8
0.31
16
129
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
45
320
1.41
1.41
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
34
229
1.49
1.40
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
34
229
1.49
1.40
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
34
229
1.49
1.40
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
34
229
1.49
1.40
1.2
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
10
46
2.17
1.39
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
21
126
1.67
1.39
1.1
1.1
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
7
29
2.41
1.39
1.0
1.0
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1124
10571
1.07
1.39
4.6
4.3
u/l
237.4
242.8
0.74
1030
9999
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
13
67
1.94
1.38
1.0
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
197
1688
1.17
1.37
1.1
1.3
u/ml
262.1
278.8
0.31
130
1049
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2454
25474
0.95
1.35
1.5
1.7
mmol/l
1.3
1.4
3.46
2135
21253
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
39
0.00
1.33
0.0
1.2
—
3772.3
—
0
26
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
110
896
1.23
1.33
1.1
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
118
1431
0.82
1.33
1.4
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
53
708
0.75
1.33
1.3
2.1
u/field
1.5
1.9
0.24
15
304
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
56
742
0.75
1.32
1.7
1.6
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
29
192
1.51
1.31
1.2
1.2
%
63.5
74.7
—
6
53
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
29
193
1.50
1.28
1.2
1.1
%
100.3
76.1
—
7
56
(3004347) Hepatitis D virus Ab [Presence] in Serum
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
22
342
0.64
1.27
1.1
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
79
994
0.79
1.27
1.2
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
73
571
1.28
1.26
1.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
33
227
1.46
1.25
1.1
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1096
11604
0.94
1.24
6.6
7.3
mmol/l
104.7
104.4
1.60
1090
11362
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
131
1097
1.20
1.22
1.1
1.2
u/l
52.0
62.9
2.09
75
744
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
23
147
1.57
1.22
1.4
1.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
7896
78030
1.04
1.22
17.2
18.5
g/l
332.3
332.1
0.70
7843
77544
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
14
240
0.58
1.22
1.1
1.3
%
46.9
38.3
—
8
159
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
24
361
0.66
1.21
3.8
1.7
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
178
2061
0.86
1.20
2.8
3.4
u/ml
460.5
574.6
0.10
160
1878
(3009214) Lutropin [Units/volume] in Serum or Plasma
254
2244
1.14
1.20
1.4
1.4
u/l
10.2
11.2
0.57
201
1821
(3013293) Extractable nuclear Ab [Presence] in Serum
9
168
0.54
1.18
2.2
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1308
12437
1.06
1.17
1.5
1.6
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
34
0.00
1.16
0.0
1.1
—
274.8
—
0
34
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
190
1651
1.15
1.15
1.1
1.4
u/ml
124.0
114.7
0.12
23
354
(3027135) IgG subclass 1 [Mass/volume] in Serum
119
995
1.20
1.15
1.3
1.4
g/l
6.5
6.7
0.23
97
690
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
13
72
1.81
1.14
1.0
1.0
u/ml
0.0
0.1
—
8
40
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
20
126
1.59
1.14
1.1
1.1
u/ml
0.0
7.8
1.02
15
94
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
57
734
0.78
1.13
1.1
1.3
mmol/l
11.9
12.0
0.02
31
196
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
216
1897
1.14
1.13
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
216
1897
1.14
1.13
1.3
1.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
29
414
0.70
1.13
1.2
2.1
umol/l
132.7
136.1
0.02
14
218
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
31
216
1.44
1.13
1.5
1.6
au/ml
53.9
84.0
—
5
28
(3008116) Ketones [Moles/volume] in Urine by Test strip
26
175
1.49
1.12
1.0
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
49
642
0.76
1.11
6.5
6.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
258
2895
0.89
1.11
1.5
1.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
161
1387
1.16
1.11
1.3
1.3
nmol/l
0.6
2.5
1.02
153
1336
(3007566) Smooth muscle Ab [Titer] in Serum
300
2694
1.12
1.10
1.3
1.2
titre
56.2
147.3
2.76
16
237
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
816
7662
1.07
1.10
3.0
2.7
ml/min/173m2
69.2
65.7
1.91
278
3035
(3013826) Glucose [Moles/volume] in Serum or Plasma
5560
54641
1.04
1.09
3.9
4.7
mmol/l
6.4
6.7
20.60
5209
51072
(3003181) Sodium [Moles/volume] in Urine
141
1646
0.85
1.08
1.3
1.4
mmol/l
61.4
63.7
0.29
105
1327
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
18
112
1.61
1.08
1.5
2.4
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
66
522
1.27
1.08
3.2
3.3
mu/l
23.8
24.9
0.12
61
498
(40758292) HTLV I+II Ab panel - Serum
22
144
1.53
1.08
1.3
1.4
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
19
120
1.58
1.08
1.2
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
198
2253
0.88
1.07
3.3
3.5
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
118
995
1.19
1.06
1.3
1.4
g/l
0.3
0.4
1.53
97
690
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
55
703
0.78
1.05
1.3
1.2
—
—
—
0
0
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
12
67
1.79
1.04
1.3
1.6
mg/l
2.2
3.7
0.55
12
45
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
40
297
1.35
1.03
1.2
1.3
%
4.1
31.3
4.17
14
38
(3038177) Helicobacter pylori Ab [Presence] in Serum
173
1509
1.15
1.03
1.2
1.2
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
76
616
1.24
1.02
2.1
2.0
ug/l
6.1
3.7
0.75
66
540
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
29
204
1.42
1.02
1.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
105
880
1.20
1.02
3.6
3.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
169
1934
0.87
1.01
3.6
2.8
umol/l
32.1
34.1
0.46
146
1646
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
160
1390
1.15
1.01
1.3
1.3
nmol/l
0.1
0.3
—
7
101
(3025577) Chromium [Mass/volume] in Blood
74
600
1.23
1.00
2.0
2.1
ug/l
3.8
2.5
0.81
56
509
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
176
2005
0.88
0.99
1.5
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
563
5240
1.08
0.99
1.2
1.3
—
—
—
0
0
(4062490)
117
993
1.18
0.99
1.3
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
230
2575
0.89
0.99
1.3
1.3
miu/ml
227.8
218.8
0.16
111
1155
(3010937) Rubella virus Ab [Presence] in Serum
9
49
1.84
0.98
1.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1250
13082
0.95
0.98
1.7
2.1
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
11
61
1.80
0.98
1.6
1.2
umol/l
72.8
86.0
0.76
11
55
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
41
309
1.33
0.97
1.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
21
140
1.50
0.97
1.6
1.6
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
117
996
1.18
0.96
1.3
1.4
g/l
2.9
2.9
0.10
96
692
(3040893) Potassium [Moles/volume] in Capillary blood
0
31
0.00
0.96
0.0
2.4
—
4.3
—
0
31
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
18
116
1.55
0.96
1.2
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
428
3947
1.09
0.96
1.4
1.4
iu/l
31.9
31.9
0.00
359
3396
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
106
1250
0.85
0.95
1.2
1.3
pmol/l
294.7
309.3
0.09
82
945
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2892
29696
0.96
0.94
2.4
2.6
u/l
58.9
57.9
0.31
2565
27337
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
34
456
0.74
0.94
1.5
1.5
mmol/l
7.5
8.0
0.54
26
276
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
6
27
2.22
0.93
1.0
1.0
g/l
0.2
0.2
—
6
21
(21494755) Public health laboratory ask at order entry panel
849
8036
1.06
0.93
1.3
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
37
277
1.34
0.93
1.3
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
16
245
0.65
0.92
1.0
1.2
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
12
70
1.72
0.92
1.0
1.0
u/ml
0.0
0.0
—
7
42
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1205
12598
0.95
0.92
2.3
2.6
%
24.5
22.4
5.62
1106
10715
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
34
453
0.75
0.91
1.3
1.6
nmol/l
1.5
4.9
2.25
29
373
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
102
0.49
0.89
1.2
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
186
1651
1.13
0.89
1.5
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
51
403
1.27
0.88
2.3
2.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
10
56
1.79
0.87
1.2
1.5
umol/24h
314.6
326.2
—
10
56
(3005322) IgE [Units/volume] in Serum or Plasma
623
5854
1.07
0.87
1.3
1.3
u/ml
214.4
219.0
0.04
584
5382
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1293
13474
0.95
0.87
2.2
2.5
g/l
2.4
2.3
0.55
1187
12464
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
6
30
2.00
0.87
1.3
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
346
3182
1.09
0.85
2.7
3.2
g/l
0.3
0.3
0.04
137
1331
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
144
1261
1.14
0.85
1.3
1.3
—
—
—
0
0
(44813793)
78
650
1.20
0.84
1.1
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
17
112
1.52
0.84
2.7
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
313
2869
1.09
0.83
2.1
2.3
%
93.9
91.7
1.21
299
2672
(3008295) Osmolality of Serum or Plasma
81
963
0.84
0.83
2.0
1.4
mosm/kgh2o
278.3
278.8
0.06
58
746
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
147
1292
1.14
0.83
1.1
1.1
g/l
1.5
1.5
0.08
132
1157
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
82
688
1.19
0.83
1.4
1.5
u/ml
22.4
20.5
0.12
11
142
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1598
15423
1.04
0.83
1.4
1.4
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
15
226
0.66
0.82
1.4
1.4
%
21.3
23.8
0.12
15
187
(44786800) Granulocytes/100 leukocytes in Body fluid
6
115
0.52
0.82
1.2
1.3
%
18.8
23.5
—
6
87
(3024471) HLA-A [Type]
21
296
0.71
0.82
1.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
24
330
0.73
0.81
1.8
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
238
2621
0.91
0.80
1.3
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
91
775
1.18
0.79
1.0
1.1
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
24
0.00
0.79
0.0
8.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
22
156
1.41
0.78
1.4
1.3
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
38
295
1.29
0.78
3.1
3.3
mg/l
7.2
7.8
0.35
29
239
(3033923) Metanephrine [Moles/time] in 24 hour Urine
27
199
1.36
0.78
1.2
1.1
umol/24h
0.7
0.6
0.19
12
87
(3012898) Urea [Moles/volume] in Urine
5
98
0.51
0.77
1.2
1.4
mmol/l
233.0
157.0
—
5
85
(3020618) Glucose [Moles/volume] in Synovial fluid
0
27
0.00
0.77
0.0
1.0
—
5.9
—
0
17
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
260
2376
1.10
0.76
1.7
1.8
iu/l
4.5
8.2
0.50
70
859
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
28
0.00
0.76
0.0
3.7
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
77
650
1.19
0.75
1.1
1.0
ng/l
732.0
720.4
0.08
57
441
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
53
431
1.23
0.75
1.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
161
0.62
0.75
1.7
3.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
2876
28113
1.03
0.74
3.2
3.2
e6/l
85.7
84.6
0.01
2021
21529
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
9
54
1.67
0.74
1.1
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
45
559
0.80
0.74
1.1
1.2
ratio
1.1
1.1
—
9
192
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
249
2276
1.10
0.73
1.4
1.5
pmol/l
107.5
164.0
1.78
242
2212
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
16
108
1.48
0.73
1.4
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
93
1077
0.86
0.72
1.0
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
77
653
1.18
0.72
1.1
1.0
ng/l
43.7
44.1
0.03
54
447
(3012494) Peanut IgE Ab [Units/volume] in Serum
17
242
0.70
0.72
1.2
1.1
u/ml
0.3
2.3
—
10
122
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
17
242
0.70
0.72
1.2
1.3
ug/l
2.6
281.3
—
9
136
(3044007) Cell count panel - Peritoneal fluid
19
264
0.72
0.70
2.1
2.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
74
627
1.18
0.70
1.1
1.2
u/l
17.0
21.8
0.87
62
525
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
21
286
0.73
0.69
1.2
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
49
400
1.23
0.69
1.6
2.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
19
135
1.41
0.68
1.2
1.1
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
12
77
1.56
0.68
1.1
1.0
—
6.9
—
0
10
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
7
42
1.67
0.68
1.3
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
9
59
1.53
0.68
1.0
1.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
76
648
1.17
0.68
1.1
1.0
ng/l
313.9
341.3
0.45
55
453
(3051611) Lipemic interference index of Serum or Plasma
114
1003
1.14
0.68
2.6
3.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
120
0.58
0.67
1.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
77
659
1.17
0.66
1.5
1.6
ml
1737.4
1956.6
—
5
161
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3552
34892
1.03
0.65
3.3
3.5
ng/l
32.7
60.7
1.31
2394
23677
(3015183) Erythrocyte sedimentation rate
50
412
1.21
0.65
1.1
1.3
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
33
416
0.79
0.64
1.1
1.1
%
103.1
93.8
0.81
20
322
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
561
5320
1.06
0.64
3.3
3.7
u/ml
69.7
61.0
0.14
540
5115
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
35
438
0.80
0.64
1.2
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
128
0.62
0.63
2.4
1.9
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
45
368
1.22
0.63
1.2
1.5
iu/ml
—
1252865.8
—
0
19
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
38
470
0.81
0.63
1.1
1.3
%
92.1
61.0
—
7
58
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
200
1827
1.10
0.63
1.6
1.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
11
165
0.67
0.62
2.5
2.7
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
12
79
1.52
0.62
1.3
1.2
ug/l
103.6
122.2
—
7
48
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1051
10130
1.04
0.62
3.7
4.1
ug/l
16.1
25.3
0.44
806
8196
(3027456) Digoxin [Moles/volume] in Serum or Plasma
147
1631
0.90
0.62
3.2
3.0
nmol/l
0.7
0.8
2.58
108
1242
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
66
562
1.18
0.62
1.3
1.3
g/l
1.5
1.5
—
7
36
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
103
0.58
0.62
1.3
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
63
738
0.85
0.60
2.2
2.7
%
11.5
11.1
0.30
63
738
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
20
0.00
0.60
0.0
2.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
140
0.64
0.60
2.0
6.0
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
45
543
0.83
0.60
2.8
2.7
%
40.5
38.5
—
9
192
(3006969) Lambda light chains [Mass/volume] in Urine
0
21
0.00
0.60
0.0
1.0
—
0.0
—
0
10
(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid
0
21
0.00
0.60
0.0
6.9
—
50.3
—
0
7
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
109
967
1.13
0.59
1.1
1.2
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
22
0.00
0.59
0.0
5.5
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
22
288
0.76
0.58
1.1
1.1
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
79
687
1.15
0.58
3.3
3.4
nmol/l
100.4
136.6
0.88
79
681
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
13
89
1.46
0.57
1.0
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
57
483
1.18
0.57
1.1
1.1
u/ml
1.9
1.7
0.04
13
142
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
263
2444
1.08
0.57
1.3
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
7
115
0.61
0.57
2.1
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
124
1380
0.90
0.57
1.1
1.1
iu/ml
32.4
7473.9
0.58
22
335
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
459
4349
1.06
0.56
3.2
4.5
mmol/l
24.2
24.2
0.06
410
3925
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
6
36
1.67
0.56
2.8
9.5
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
21
275
0.76
0.56
1.2
1.3
mmol/l
3.1
3.3
0.11
21
246
(40765096) Chromosome analysis panel by Banding
33
265
1.25
0.56
1.1
1.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
74
644
1.15
0.55
1.1
1.2
u/l
75.4
83.5
0.43
66
556
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
12
171
0.70
0.54
1.1
1.1
—
5.2
—
0
25
(3000285) Sodium [Moles/volume] in Blood
8
124
0.64
0.54
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
803
7726
1.04
0.54
6.9
8.6
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
9
60
1.50
0.54
1.0
1.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
73
836
0.87
0.54
1.3
1.3
nmol/l
1.3
1.5
1.02
59
751
(3037692) Legionella sp identified in Specimen by Organism specific culture
28
350
0.80
0.53
1.6
1.4
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
6
39
1.54
0.53
1.0
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
110
1225
0.90
0.53
1.4
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
60
694
0.86
0.51
1.6
2.1
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
6
40
1.50
0.51
1.0
1.1
—
20.1
—
0
9
(3030313) Adrenal Ab [Titer] in Serum
10
67
1.49
0.49
1.1
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
10
67
1.49
0.49
1.9
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
14
101
1.39
0.49
1.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
56
647
0.86
0.48
1.9
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
39
326
1.20
0.48
1.1
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
177
1913
0.92
0.47
4.2
5.5
iu/ml
672.7
2127.4
0.85
21
280
(3042111) Morphology [Interpretation] in Bone marrow Narrative
145
1574
0.92
0.44
1.5
1.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
171
1585
1.08
0.44
1.8
3.4
%
64.6
64.5
0.00
171
1580
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2330
22892
1.02
0.44
2.2
2.3
mg/l
2.8
2.9
2.26
1846
19679
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
59
517
1.14
0.43
1.1
1.1
u/l
19.5
26.7
1.09
53
385
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
15
196
0.76
0.42
6.6
5.4
u/l
26.0
77.3
—
5
66
(3016273) Islet cell 512 Ab [Units/volume] in Serum
8
56
1.43
0.42
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
162
1502
1.08
0.42
1.1
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
12
87
1.38
0.42
1.2
1.2
umol/24h
1.6
1.7
0.32
12
87
(4034850)
288
3042
0.95
0.42
8.9
9.8
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
8
58
1.38
0.41
5.0
3.4
—
0.0
—
0
9
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
59
519
1.14
0.41
1.1
1.1
u/l
80.3
88.0
0.43
51
398
(3041184) Isoniazid [Presence] in Urine
0
15
0.00
0.41
0.0
2.9
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
122
1328
0.92
0.41
1.3
1.4
mu/l
76.3
54.0
0.51
108
1185
(3017704) Immunofixation for Urine
43
498
0.86
0.40
1.7
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
26
314
0.83
0.39
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
69
616
1.12
0.39
1.4
1.8
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
30
357
0.84
0.39
1.2
1.2
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
7
105
0.67
0.39
1.7
1.8
mg/l
2.2
1.6
—
7
87
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
136
1469
0.92
0.39
2.5
2.7
u/ml
440.0
1521.2
—
8
86
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
81
732
1.11
0.38
1.5
2.0
%
13.7
14.8
0.24
32
315
(40765089) Chromosome analysis panel - Blood by G-banded
23
188
1.22
0.37
1.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
11
147
0.75
0.37
8.5
6.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
11
147
0.75
0.37
4.3
3.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
49
430
1.14
0.37
1.4
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
49
430
1.14
0.37
1.4
1.6
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
11
81
1.36
0.36
1.9
2.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
207
2194
0.94
0.36
1.8
2.1
—
—
—
0
0
(3001729) Color of Synovial fluid
5
76
0.66
0.35
2.0
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
2478
25139
0.98
0.35
1.3
1.4
—
—
—
0
0
(3025315) Body weight
5
78
0.64
0.35
4.6
4.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
401
4176
0.96
0.35
1.7
1.7
g/l
1.4
1.6
5.40
330
3584
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
744
7227
1.03
0.35
2.9
3.9
ng/l
71.9
90.2
11.76
630
6212
(40758358) Immune stain study
6
43
1.40
0.35
1.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
48
423
1.14
0.34
1.3
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
32
373
0.86
0.34
3.0
2.6
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
58
518
1.12
0.34
1.8
1.7
mmol/24h
8.9
5.7
—
6
40
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
138
1479
0.93
0.34
1.6
1.3
u/l
33.2
35.8
0.11
120
1286
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
11
82
1.34
0.34
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
38
330
1.15
0.33
1.1
1.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
54
481
1.12
0.33
1.1
1.1
u/ml
0.5
1.9
—
9
119
(4212803)
12
91
1.32
0.33
1.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
11
144
0.76
0.33
1.3
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
24
284
0.84
0.31
1.5
1.4
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
7
96
0.73
0.30
1.7
1.3
—
526.2
—
0
11
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
87
944
0.92
0.30
1.2
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
198
1879
1.05
0.30
2.2
2.9
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
73
797
0.92
0.29
1.7
1.9
mg/l
3.5
4.0
0.66
67
757
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
661
6790
0.97
0.29
1.6
1.6
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
29
335
0.87
0.29
2.4
2.8
umol/l
28.5
28.5
0.00
22
250
(21494890) Protein electrophoresis panel - 24 hour Urine
91
983
0.93
0.29
1.9
2.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
127
1190
1.07
0.29
1.6
1.6
%
47.2
57.1
2.14
94
737
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1439
14638
0.98
0.29
1.8
1.8
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
33
377
0.87
0.29
3.8
4.8
mg/l
51.3
1195.3
0.81
24
276
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
303
3154
0.96
0.29
2.7
2.7
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
71
650
1.09
0.28
1.3
1.3
u/ml
0.3
1.4
2.09
40
312
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
282
2705
1.04
0.28
2.3
2.6
g/l
3.6
3.6
0.11
261
2574
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
14
112
1.25
0.28
1.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
12
94
1.28
0.28
1.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
12
94
1.28
0.28
1.8
2.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
32
280
1.14
0.27
1.4
1.6
ug/l
10.1
8.7
1.01
32
280
(44806071)
9
119
0.76
0.27
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
268
2792
0.96
0.27
1.6
1.5
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
44
490
0.90
0.27
9.8
12.0
mmol/l
0.6
0.6
0.04
38
449
(3000060) B lymphocytes [#/volume] in Blood
28
243
1.15
0.26
1.5
2.2
e6/l
188.8
242.1
0.25
16
126
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
188
1791
1.05
0.26
3.3
3.7
u/ml
18.6
35.8
5.20
182
1730
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
8
67
1.19
0.26
1.0
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
2795
28241
0.99
0.26
3.5
4.1
ph
7.4
7.4
0.25
206
5487
(3018851) Theophylline [Moles/volume] in Serum or Plasma
11
86
1.28
0.26
2.5
1.6
umol/l
41.9
42.5
0.03
11
86
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1011
10304
0.98
0.25
1.8
1.6
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
74
1.22
0.25
1.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
21
180
1.17
0.23
2.3
2.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
4041
40702
0.99
0.23
4.0
4.9
g/l
36.4
35.5
23.07
3702
37799
(3047189) Immunofixation for 24 hour Urine
49
447
1.10
0.23
1.7
1.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
7
95
0.74
0.22
1.0
1.2
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
41
1.22
0.22
1.0
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
14
167
0.84
0.21
1.9
1.9
umol/l
18.9
17.7
0.21
14
167
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
10
0.00
0.21
0.0
1.0
—
20.7
—
0
10
(3001218) Citrate [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
120
1264
0.95
0.21
1.3
1.3
—
—
—
0
0
(3045177) Copper [Moles/volume] in Urine
0
13
0.00
0.21
0.0
1.1
—
0.2
—
0
6
(44816559) Phosphatidylethanol [Mass/volume] in Blood
176
1689
1.04
0.20
1.5
1.3
—
—
—
0
0
(3021367) Citalopram [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
83.7
—
0
7
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
35
317
1.10
0.19
1.8
1.7
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
51
1.18
0.19
2.8
2.1
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
6
51
1.18
0.19
1.0
1.3
ug/g
147.0
148.2
—
6
41
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
66
618
1.07
0.18
1.2
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
8
69
1.16
0.16
1.1
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
516
5258
0.98
0.16
1.6
1.5
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
78
822
0.95
0.16
1.9
1.4
ug/l
3.8
4.3
0.25
63
688
(3024928) Oxygen saturation in Venous blood
198
1919
1.03
0.15
2.0
3.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
205
2113
0.97
0.15
1.5
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
153
1585
0.96
0.15
3.2
3.4
%
1.8
1.5
0.33
122
1230
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
12
102
1.18
0.15
1.3
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
88
922
0.95
0.15
4.3
4.9
u/ml
31.7
100.9
3.34
30
263
(3032868) Hemoglobin electrophoresis panel in Blood
9
83
1.08
0.14
1.7
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
335
3424
0.98
0.14
3.5
3.5
u/ml
523.4
1985.6
0.95
285
2917
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
7
88
0.80
0.14
1.3
1.2
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
32
347
0.92
0.14
1.4
2.1
%
25.8
29.2
0.84
32
324
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
26
284
0.92
0.13
1.2
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
33
355
0.93
0.12
1.6
1.8
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
13
148
0.88
0.12
1.3
1.6
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
10
85
1.18
0.12
1.1
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
155
1596
0.97
0.12
1.8
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
273
2788
0.98
0.12
1.7
2.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
772
7811
0.99
0.12
2.1
2.3
ug/l
6.8
7.3
0.39
635
6860
(3037756) Immunofixation for Serum or Plasma
199
1942
1.03
0.11
1.8
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1425
14359
0.99
0.11
2.0
2.1
s
29.6
29.8
0.63
1393
13938
(4281824)
119
1154
1.03
0.10
1.2
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
43
454
0.95
0.10
1.9
2.1
ug/min
27.1
170.6
1.89
15
109
(43055514) Macroprolactin [Presence] in Serum or Plasma
19
173
1.10
0.10
1.3
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
86
891
0.96
0.10
2.6
3.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
45
1.11
0.09
16.2
8.2
—
—
—
0
0
(4024509)
94
971
0.97
0.09
1.5
1.6
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
46
1.09
0.09
1.2
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
10
114
0.88
0.09
1.2
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
118
1149
1.03
0.09
3.2
3.4
nmol/l
5.3
10.6
0.55
111
1121
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1076
10684
1.01
0.08
1.6
1.7
%
1.4
1.5
1.04
927
9307
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
5
62
0.81
0.08
1.8
1.2
u/l
26.4
1641.3
—
5
56
(4133840)
22
236
0.93
0.08
1.1
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
34
358
0.95
0.07
1.4
1.5
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
73
0.82
0.07
1.0
1.2
u/l
9.8
13.8
—
6
73
(3016038) Potassium [Moles/volume] in Urine
59
611
0.97
0.07
1.1
1.2
mmol/l
42.8
35.1
1.13
49
519
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
8
77
1.04
0.07
7.6
2.5
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
9
85
1.06
0.07
1.2
5.1
g/mol
12.9
59.9
—
9
71
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
126
1234
1.02
0.07
1.5
1.4
nmol/l
0.2
0.4
2.94
96
919
(3028707) Methadone [Presence] in Urine by Screen method
128
1255
1.02
0.06
2.1
2.7
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
21
197
1.07
0.06
4.7
2.9
ng/l
87.8
127.7
—
10
80
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
133
1306
1.02
0.06
2.6
2.5
u/ml
4.0
1270.7
1.04
126
1255
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
15
139
1.08
0.05
1.3
1.2
ng/l
58.2
89.1
—
8
94
(3036481) Cortisol [Moles/volume] in Serum or Plasma
867
8717
0.99
0.05
2.2
2.3
nmol/l
378.7
372.1
0.43
800
8020
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
52
505
1.03
0.05
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
23
219
1.05
0.04
1.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
22
231
0.95
0.04
1.2
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
27
259
1.04
0.04
1.3
1.7
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
286
2881
0.99
0.03
3.6
3.3
ratio
2.1
2.4
—
8
238
(3027945) Reticulocytes/100 erythrocytes in Blood
1020
10233
1.00
0.03
2.3
2.6
%
1.7
1.8
3.76
876
9086
(3021387) Prolactin [Units/volume] in Serum or Plasma
271
2690
1.01
0.03
1.6
1.7
mu/l
277.2
306.3
1.19
245
2432
(3000764) Benzodiazepines [Presence] in Urine
280
2819
0.99
0.03
1.6
2.0
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
34
350
0.97
0.03
1.6
2.2
%
11.1
10.1
0.19
34
321
(3051651) Icteric interference index of Serum or Plasma
57
581
0.98
0.02
2.6
3.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
261
2627
0.99
0.02
1.7
2.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
72
709
1.02
0.02
1.5
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
286
2844
1.01
0.02
1.6
2.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
297
2957
1.00
0.01
3.5
3.4
mg/l
40.5
72.9
0.99
257
2391
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
327
3283
1.00
0.01
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
285
2838
1.00
0.01
1.6
2.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
45
458
0.98
0.01
1.1
1.1
u/ml
11.7
19.1
—
7
45
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
161
1620
0.99
0.01
1.2
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
34
347
0.98
0.01
1.3
2.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
773
7739
1.00
0.00
2.3
2.6
e9/l
68.4
70.4
0.86
553
5860
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
295
2956
1.00
0.00
3.5
3.4
mg/l
33.9
47.3
1.39
258
2390
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
20
203
0.99
0.00
1.7
2.0
ug/l
5.0
2.2
0.56
13
106
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
49
493
0.99
0.00
1.2
1.8
u/field
0.7
2.7
4.38
19
358
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
67
667
1.00
0.00
1.6
1.6
u/l
5.3
6.3
0.14
27
326
(3020717) Zinc [Moles/volume] in Serum or Plasma
49
492
1.00
0.00
1.2
1.5
umol/l
38.5
25.8
1.31
44
468
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
40
401
1.00
0.00
2.7
2.2
umol/l
48.6
54.1
0.54
34
330
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
37.2
—
0
6
(3036005) Urine sediment comments by Light microscopy Narrative
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
19
190
1.00
0.00
1.6
1.6
ng/l
76.3
128.5
2.07
19
190
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
122
1220
1.00
0.00
1.0
1.1
—
—
—
0
0
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
7
0.00
0.00
0.0
6.4
—
10.7
—
0
7
(3014178) Parietal cell Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
6
69
0.87
0.00
2.3
4.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
12
120
1.00
0.00
1.0
1.1
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
8
81
0.99
0.00
1.4
2.4
umol/l
519.3
454.4
—
8
75
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
5
54
0.93
0.00
1.2
1.1
mmol/l
7.8
8.3
—
5
54
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
6.6
4.5
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
7
0.00
0.00
0.0
1.1
—
69.1
—
0
7
(3002619) Bacteria identified in Specimen by Culture
18
180
1.00
0.00
1.1
1.3
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009179) Lactate [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
1.8
—
0
5
(3018001) Oat IgE Ab [Units/volume] in Serum
5
55
0.91
0.00
1.0
1.0
—
0.3
—
0
22
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
6
68
0.88
0.00
1.0
1.0
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
6
0.00
0.00
0.0
1.2
—
36.9
—
0
6
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
9
91
0.99
0.00
1.0
1.1
—
—
—
0
0
(3008896) Cortisol [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045759) Histamine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.0
—
284.7
—
0
6
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3028468) Fragments [Presence] in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
8
86
0.93
0.00
2.1
2.1
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

Index endpoint: AB1_LYME – Lyme disease

GWS hits: 3

This endpoint is excluded (different definition than used in FinnGen).